Newsfile Corp
06 Oct 2026, 02:52 UTC · 58m ago
ROSEN, A LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS
Impact · against what's priced in
The notice regarding the lead plaintiff deadline for HIMS and HON represents a procedural progression of existing legal risks rather than new material catalysts. For HIMS, the specific allegations regarding data privacy and billing are already factored into the current valuation's discount.
- HON−0.05
Already priced in
- The price assumes
The risk of a federal securities law investigation by Robbins Geller Rudman & Dowd LLP.





